Euthymics Bioscience, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2009-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.euthymics.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Phase 2
Completed
- Conditions
- Major Depressive Disorder
- Interventions
- Drug: EB-1010 25mg BIDDrug: EB-1010 50mg BIDDrug: SSRI ActiveDrug: Placebo
- First Posted Date
- 2011-03-18
- Last Posted Date
- 2015-12-04
- Lead Sponsor
- Euthymics BioScience, Inc.
- Target Recruit Count
- 342
- Registration Number
- NCT01318434
- Locations
- 🇺🇸
Pacific Clinical Research Medical Group, Upland, California, United States
🇺🇸Southwest Research, Inc., Beverly Hills, California, United States
🇺🇸Synergy Clinical Research Center, National City, California, United States
News
No news found